Immunoactivities of fractions of Elephantopus scaber linn leaf in NK cells, CD8+ T cells, and perforin
DOI:
https://doi.org/10.56782/pps.304Keywords:
Elephantopus scaber Linn, immunoactivities, fraction, NK cells, CD8+ T cells, PerforinAbstract
The goal of this study is to determine the effect of a fraction of Elephantopus scaber Linn leaf extract on NK cells, CD8+ T cells, and perforin in male white mice using one dose of Elephantopus scaber Linn fraction at 30 mg/kg BW. In this study, 25 experimental animals were divided into 5 groups there are negative control, positive control, and 3 fractions of Elephantopus scaber Linn leaf, namely n-hexane, ethyl acetate, and butanol. Mice were treated with Elephantopus scaber Linn leaf fraction for 7 days after being previously stimulated by the SARS-Cov-2 virus antigen (inavac®). The animals were then analyzed on day 8. Duncan analysis was performed after One-Way ANOVA was used to evaluate the data. The test results showed that the concentration of NK cells increased slightly although it did not significantly increase (**p < 0.01; *p < 0.05) and the concentration of CD8+ T cells and perforin significantly decreased (**p < 0.01; *p < 0.05). It is concluded that a fraction of Elephantopus scaber Linn leaf shows immunomodulatory activity.
Downloads
References
1. Kalyniukova, A.; Holuša, J.; et al. Application of deep eutectic solvents for separation and determination of bioactive compounds in medicinal plants. Ind. Crops Prod., 2021, 172, Art. No: 114047. DOI: 10.1016/j.indcrop.2021.114047 DOI: https://doi.org/10.1016/j.indcrop.2021.114047
2. Gusain, P.; Uniyal, D. P.; et al. Conservation and sustainable use of medicinal plants. In Preparation of Phytopharmaceuticals for the Management of Disorders. Egbuna, C., Mishra, A.P., Eds.; Elsevier, 2021; pp. 409–427. DOI: https://doi.org/10.1016/B978-0-12-820284-5.00026-5
3. Xie, S.; Wang, Y.; et al. Mechanisms of the antiangiogenic effects of aspirin in cancer. Eur. J. Pharmacol. 2021, 898, 173989. DOI: 10.1016/j.ejphar.2021.173989 DOI: https://doi.org/10.1016/j.ejphar.2021.173989
4. Rates, S. M. Plants as source of drugs. Toxicon. 2001, 39 (5), 603–613. DOI: 10.1016/s0041-0101(00)00154-9 DOI: https://doi.org/10.1016/S0041-0101(00)00154-9
5. Pascali, J. P.; Fai, P. Opiates. In Encyclopedia of Forensic Sciences, 3rd ed.; Houck, M.H., Eds.; Elseiver, 2023; 7-16. DOI: https://doi.org/10.1016/B978-0-12-823677-2.00049-0
6. Molassiotis, A.; Smith, J.A. Symptomatic Treatment of Cough Among Adult Patients With Lung Cancer: CHEST Guideline and Expert Panel Report. Chest 2017, 151 (4), 861-874. DOI: 10.1016/j.chest.2016.12.028 DOI: https://doi.org/10.1016/j.chest.2016.12.028
7. Akpomie, T. M.; Augustine, A. U.; et al. Determination of Caffeine Content in Two Varieties of Kola Nut and Some Tea Products Sold in Lafia, North Central Nigeria. Pacific J. Sci. Technol. 2020, 21 (2), 272–278. DOI: 10.13140/RG.2.2.17376.71680
8. John, D. K.; Souza, K. D. S.; et al. Overview of cocaine identification by vibrational spectroscopy and chemometrics. Forensic Sci. Int. 2023, 342, Art. No: 111540. DOI: 10.1016/j.forsciint.2022.111540 DOI: https://doi.org/10.1016/j.forsciint.2022.111540
9. Chaki, R.; Ghosh, N.; et al. Phytopharmacology of herbal biomolecules. In Herbal Biomolecules in Healthcare Applications. Mandal, S.C., Nayak, A.K., Eds. Academic Press, 2022; pp. 101–119. DOI: https://doi.org/10.1016/B978-0-323-85852-6.00026-3
10. Kelik, M. Tapak Liman (Elephantopus scaber L) As Immunostimulant and Its Effect on Lymphocyte Differentiation in Mice BALB/C. Biol. Med. Nat. Prod. Chem. 2015, 4 (2), 49-51. DOI: 10.14421/biomedich.2015.42.49-51 DOI: https://doi.org/10.14421/biomedich.2015.42.49-51
11. Jamal, R. K.; Jose, V. Determination of phytochemicals by GC-MS in methanol extract of Elephantopus scaber L. J. Pharmacogn. Phytochem. 2017, 6 (6), 807–813.
12. Aldi, Y.; Dillasamola, D.; et al. Immunomodulator activity of ethanol extract of tapak liman leaves (Elephantopus scaber Linn.). Pharmacogn. J. 2019, 11 (6), 1419–1427. DOI: 10.5530/PJ.2019.11.220 DOI: https://doi.org/10.5530/pj.2019.11.220
13. Sheeba, K. O.; Wills, P. J.; et al. Antioxidant and antihepatotoxic efficacy of methanolic extract of Elephantopus scaber Linn in Wistar rats. Asian Pacific J. Trop. Dis. 2012, 2 (2), S904–S908. DOI: 10.1016/S2222-1808(12)60289-8 DOI: https://doi.org/10.1016/S2222-1808(12)60289-8
14. Phumthum, M.; Sadgrove, N.J. High-value plant species used for the treatment of ‘fever’ by the karen hill tribe people. Antibiotics 2020, 9 (5), Art. No: 220. DOI: 10.3390/antibiotics9050220 DOI: https://doi.org/10.3390/antibiotics9050220
15. Nguyen, P.A.T.; Khang, D.T.; et al. The complete chloroplast genome of Elephantopus scaber L. (Vernonioideae, Asteraceae), a useful ethnomedicinal plant in asia. Mitochondrial DNA Part B Resour. 2023, 8 (9), 936–941. DOI: 10.1080/23802359.2023.2252944 DOI: https://doi.org/10.1080/23802359.2023.2252944
16. Kabeer, F. A.; Prathapan, R. Phytopharmacological Profile of Elephantopus scaber. Pharmacologia 2014, 5 (8), 272–285. DOI: 10.5567/pharmacologia.2014.272.285 DOI: https://doi.org/10.5567/pharmacologia.2014.272.285
17. Daisy, P. A study on the regenerative potential of the root and leaf extracts of Elephantopus scaber L.: An antidiabetic approachats through up-regulated heme oxygenase-1 (HO-1) expression. African J. Pharm. Pharmacol. 2011, 5 (16), 1832–1837. DOI: 10.5897/ajpp10.332 DOI: https://doi.org/10.5897/AJPP10.332
18. Singh, S. D. J.; Krishna, V.; et al. Wound healing activity of the leaf extracts and deoxyelephantopin isolated from Elephantopus scaber Linn. Indian J. Pharmacol. 2005, 37 (4), 238–242. DOI: 10.4103/0253-7613.16570 DOI: https://doi.org/10.4103/0253-7613.16570
19. Silalahi, M. Utilization of Elephantopus scaber as traditional medicine and its bioactivity. GSC Biol. Pharm. Sci. 2021, 15 (1), 112–118. DOI: 10.30574/gscbps.2021.15.1.0106 DOI: https://doi.org/10.30574/gscbps.2021.15.1.0106
20. Yulia, M.; Aldi, Y.; et al. Viability Study of Tapak Liman (Elephantopus scaber Linn) Leaves Toward Raw 264.7 Cells. African J. Biol. Sci. 2024, 6 (7), 3226–3232. DOI: 10.48047/AFJBS.6.7.2024
21. Mendhulkar, V. D.; Kharat, S. N. HPLC Assay, Phytochemical, FTIR Characterization and Studies on Antioxidant Activity of Elephantopus scaber (Linn) Using Six Different Soxhlet Leaf Extract. Der Pharma Chemica. 2017, 9 (23), 18–28.
22. Kabiru, A.; Por, L. Y. Elephantopus Species : Traditional Uses, Pharmacological Actions and Chemical Composition. Adv. Life Sci. Technol. 2013, 15, 6–14.
23. Wang, J.; Li, P.; et al. Bioactivities of compounds from Elephantopus scaber, an ethnomedicinal plant from Southwest China. Evid. Based Complement. Altern. Med. 2014, 2014, Art. No: 569594. DOI: 10.1155/2014/ 569594 DOI: https://doi.org/10.1155/2014/569594
24. Fazil, W. F. W. M.; Amanah, A.; et al. The Effects of Deoxyelephantopin on the Akt/mTOR/P70S6K Signaling Pathway in MCF-7 Breast Carcinoma Cells In Vitro. J. Pharmacol. Pharmacother. 2022, 13 (2), 148–159. DOI: 10.1177/0976500X221114003 DOI: https://doi.org/10.1177/0976500X221114003
25. Than, N. N.; Fotso, S., et al. Sesquiterpene lactones from Elephantopus scaber. Z. Naturforsch. Sect. B 2005, 60 (2), 200–204. DOI: 10.1515/znb-2005-0212 DOI: https://doi.org/10.1515/znb-2005-0212
26. Hiradeve, S.; Rangari, V. Elephantopus scaber Linn.: A review on its ethnomedical, phytochemical and pharmacological profile. J. Appl. Biomed. 2014, 12 (2), 49–61. DOI: 10.1016/j.jab.2014.01.008
27. Chan, C. K.; Supriady, H.; et al. Elephantopus scaber induces apoptosis through ROS-dependent mitochondrial signaling pathway in HCT116 human colorectal carcinoma cells. J. Ethnopharmacol. 2015, 168, 291–304. DOI: 10.1016/j.jep.2015.03.072 DOI: https://doi.org/10.1016/j.jep.2015.03.072
28. Nakagawa-Goto, K.; Chen, J-Y.; et al. Novel sesquiterpene lactone analogues as potent anti-breast cancer agents. Mol. Oncol. 2016, 10 (6), 921–937. DOI: 10.1016/j.molonc.2016.03.002 DOI: https://doi.org/10.1016/j.molonc.2016.03.002
29. Verma, S. S.; Rai, V.; et al. Isodeoxyelephantopin, a Sesquiterpene Lactone Induces ROS Generation, Suppresses NF-κB Activation, Modulates LncRNA Expression and Exhibit Activities Against Breast Cancer. Sci. Rep. 2019, 9 (1), Art. No: 17980. DOI: 10.1038/s41598-019-52971-3 DOI: https://doi.org/10.1038/s41598-019-52971-3
30. Kabeer, F. A.; Sreedevi, G. B.; et al. Antineoplastic effects of deoxyelephantopin, a sesquiterpene lactone from Elephantopus scaber, on lung adenocarcinoma (A549) cells. J. Integr. Med. 2013, 11(4), 269–277. DOI: 10.3736/jintegrmed2013040 DOI: https://doi.org/10.3736/jintegrmed2013040
31. Wang, Y.; Zhang, J.; et al. Isodeoxyelephantopin induces protective autophagy in lung cancer cells via Nrf2-p62-keap1 feedback loop. Cell Death Dis. 2017, 8 (6), Art. No: e2876. DOI: 10.1038/cddis.2017.265 DOI: https://doi.org/10.1038/cddis.2017.265
32. Cvetanova, B.; Li, M-Y.; at al. Sesquiterpene lactone deoxyelephantopin isolated from Elephantopus scaber and its derivative detd-35 suppress BRAFV600E mutant melanoma lung metastasis in mice. Int. J. Mol. Sci. 2021, 22 (6), Art. No: 3226. DOI: 10.3390/ijms22063226 DOI: https://doi.org/10.3390/ijms22063226
33. Sandra, F.; Hayuningtyas, R. A.; et al. Elephantopus scaber Linn. Leaf Extract Sensitizes Doxorubicin in Inducing Apoptosis in HSC-3 Tongue Cancer Cells through Inhibiting Survivin Activity at Thr34. Indones. Biomed. J. 2024, 16 (4), 372–378. DOI: 10.18585/inabj.v16i4.3096 DOI: https://doi.org/10.18585/inabj.v16i4.3096
34. Gao, Y.; Nie, Z.; et al. Scabertopin Derived from Elephantopus scaber L. Mediates Necroptosis by Inducing Reactive Oxygen Species Production in Bladder Cancer In Vitro. Cancers (Basel) 2022, 14 (23), Art. No: 5976. DOI: 10.3390/cancers14235976 DOI: https://doi.org/10.3390/cancers14235976
35. Sadeghalvad, M.; Mohammadi-Motlagh, H. R.; et al. Structure and Function of the Immune System, In Encyclopedia of Infection and Immunity.; Rezaei, N., Eds.; Elsevier, 2022; pp. 24–38. DOI: https://doi.org/10.1016/B978-0-12-818731-9.00193-2
36. Rudd-Schmidt, J. A.; Trapani, J. A.; et al. Distinguishing perforin-mediated lysis and granzyme-dependent apoptosis, In Methods in Enzymology, L.; Galluzzi, Rudqvist, N. P., Eds., Academic Press, 2019; pp. 291–306. DOI: https://doi.org/10.1016/bs.mie.2019.07.034
37. Trapani, J. A. Granzymes: family of lymphocyte granule serine proteases. Genome Biol. 2001, 2 (12), Art. No: REVIEWS3014. DOI: 10.1186/gb-2001-2-12-reviews3014 DOI: https://doi.org/10.1186/gb-2001-2-12-reviews3014
38. Hiradeve, S. M.; Rangari, V. D. Elephantopus scaber Linn.: A review on its ethnomedical, phytochemical and pharmacological profile J. Appl. Biomed. 2014, 12 (2), 49–61. DOI: 10.1016/j.jab.2014.01.008 DOI: https://doi.org/10.1016/j.jab.2014.01.008
39. Doan, H. V.; Hoseinifar, S. H.; et al. Effects of elephant’s foot (Elephantopus scaber) extract on growth performance, immune response, and disease resistance of nile tilapia (Oreochromis niloticus) fingerlings. Fish Shellfish Immunol. 2019, 93, 328–335. DOI: 10.1016/j.fsi.2019.07.061 DOI: https://doi.org/10.1016/j.fsi.2019.07.061
40. Aldi, Y.; Megaraswita.; et al. Effect of Elephantopus scaber linn. Leaf extract on mouse immune system. Trop. J. Pharm. Res. 2019, 18 (10), 2045–2050. DOI: 10.4314/tjpr.v18i10.7 DOI: https://doi.org/10.4314/tjpr.v18i10.7
41. Kementerian Kesehatan Republik Indonesia. Farmakope Herbal Indonesia.; Kementerian Kesehatan Republik Indonesia: Jakarta, Indonesia, 2017, 531.
42. Dillasamola, D.; Aldi, Y.; et al. Study of Active Isolated Compounds From Sungkai Leaf (Peronema Canescens Jack) As Immunostimulant From Exposure of the Sars-Cov-2 Virus Antigen To Natural Killer Cells. Int. J. Appl. Pharm. 2024, 16 (1), 11–16. DOI: 10.22159/ijap.2024.v16s1.02 DOI: https://doi.org/10.22159/ijap.2024.v16s1.02
43. Dita, M. C. Enzyme-Linked Immunosorberat Assay (ELISA): A Narrative Literature Review. Nat. Sci. Eng. Technol. J. 2021, 1 (2), 24–31. DOI: 10.37275/nasetjournal.v1i2.6 DOI: https://doi.org/10.37275/nasetjournal.v1i2.6
44. Sakamoto, S.; Putalun, W.; et al. Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites. J. Nat. Med. 2018, 72 (1), 32–42. DOI: 10.1007/s11418-017-1144-z DOI: https://doi.org/10.1007/s11418-017-1144-z
45. Prager, I.; Watzl, C. Mechanisms of natural killer cell-mediated cellular cytotoxicity. J. Leukoc. Biol. 2019, 105 (6), 1319–1329. DOI: 10.1002/JLB.MR0718-269R DOI: https://doi.org/10.1002/JLB.MR0718-269R
46. Wang, Z.; Guan, D.; et al. Glycolysis and Oxidative Phosphorylation Play Critical Roles in Natural Killer Cell Receptor-Mediated Natural Killer Cell Functions. Front. Immunol. 2020, 11, Art. No: 202. DOI: 10.3389/fimmu.2020.00202 DOI: https://doi.org/10.3389/fimmu.2020.00202
47. Osuna-Espinoza, K. Y.; Rosas-Taraco, A. G. Metabolism of NK cells during viral infections. Front. Immunol. 2023, 14, Art. No: 1064101. DOI: 10.3389/fimmu.2023.1064101 DOI: https://doi.org/10.3389/fimmu.2023.1064101
48. Toffoli, E. C.; Sheikhi, A.; et al. Natural killer cells and anti-cancer therapies: Reciprocal effects on immune function and therapeutic response. Cancers (Basel) 2021, 13 (4), Art. No: 711. DOI: 10.3390/cancers13040711 DOI: https://doi.org/10.3390/cancers13040711
49. Radziszewska, A.; Moulder, Z.; et al. CD8+ T Cell Phenotype and Function in Childhood and Adult-Onset Connective Tissue Disease. Int. J. Mol. Sci. 2022, 23 (19), Art. No: 11431. DOI: 10.3390/ijms231911431 DOI: https://doi.org/10.3390/ijms231911431
50. Berg, R. E.; Forman, J. The role of CD8 T cells in innate immunity and in antigen non-specific protection. Curr. Opin. Immunol. 2006, 18 (3), 338–343. DOI: 10.1016/j.coi.2006.03.010 DOI: https://doi.org/10.1016/j.coi.2006.03.010
51. Murali-Krishna, K.; Altman, J.; et al. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection. Immunity 1998, 8 (2), 177–187. DOI: 10.1016/S1074-7613(00)80470-7 DOI: https://doi.org/10.1016/S1074-7613(00)80470-7
52. Osińska, I.; Popko, K.; et al. Perforin: An important player in immune response. Cent. Eur. J. Immunol. 2014, 39 (1), 109–115. DOI: 10.5114/ceji.2014.42135 DOI: https://doi.org/10.5114/ceji.2014.42135
53. Al Moussawy, M.; Abdelsamed, H. A. Non-cytotoxic functions of CD8 T cells: ‘repentance of a serial killer. Front. Immunol. 2022, 13, Art. No: 1001129. DOI: 10.3389/fimmu.2022.1001129 DOI: https://doi.org/10.3389/fimmu.2022.1001129
54. Chu, J.; Gao, F.; et al. Natural killer cells: a promising immunotherapy for cancer. J. Transl. Med. 2022, 20 (1), Art. No: 240. DOI: 10.1186/s12967-022-03437-0 DOI: https://doi.org/10.1186/s12967-022-03437-0
55. Spicer, J. A.; Huttunen, K. M.; et al. Small Molecule Inhibitors of Lymphocyte Perforin as Focused Immunosuppressants for Infection and Autoimmunity. J. Med. Chem. 2022, 65 (21), 14305–14325. DOI: 10.1021/acs.jmedchem.2c01338 DOI: https://doi.org/10.1021/acs.jmedchem.2c01338
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Mega Yulia, Yufri Aldi, Hansen Nasif, Fatma Sri Wahyuni, Dachriyanus
This work is licensed under a Creative Commons Attribution 4.0 International License.
For all articles published in Prospects in Pharmaceutical Sciences copyright is retained by the authors. The journal publishes articles in the Open Access policy, within the CC BY 4.0 licence.
This is a human-readable summary of (and not a substitute for) the license. Disclaimer.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
How to Cite
